Improving Office Based Treatment of Opioid Use Disorder With Technology

Summary

The goal of this study is to evaluate whether using a novel drug-device combination to deliver buprenorphine/naloxone (B/N) to patients in office-based treatment for Opioid Use Disorder (OUD) is an effective way to improve compliance and treatment outcomes. The system introduces psychological and behavioral supports in addition to securing the medication between doses.

Timeline

Start

2018-12-01

Primary completion

2020-09

Completion

2020-09

Drugs

Indications